Moore Capital Management, LP Atea Pharmaceuticals, Inc. Transaction History
Moore Capital Management, LP
- $5.98 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding AVIR
# of Institutions
119Shares Held
49.6MCall Options Held
108KPut Options Held
327K-
Black Rock Inc. New York, NY9.24MShares$29.9 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.15MShares$19.9 Million0.71% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.54MShares$17.9 Million14.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$15.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.08MShares$13.2 Million2.01% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $269M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...